CERo Therapeutics Holdings Inc (NASDAQ: CERO) flaunted slowness of -10.00% at $0.05, before settling in for the price of $0.06 at the close. Taking a more long-term approach, CERO posted a 52-week range of $0.05-$12.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. This publicly-traded company’s shares outstanding now amounts to $147.54 million, simultaneously with a float of $77.92 million. The organization now has a market capitalization sitting at $8.12 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1274, while the 200-day Moving Average is $0.6422.
CERo Therapeutics Holdings Inc (CERO) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the CERo Therapeutics Holdings Inc industry. CERo Therapeutics Holdings Inc’s current insider ownership accounts for 48.16%, in contrast to 1.45% institutional ownership. According to the most recent insider trade that took place on Dec 13 ’24, this organization’s 10% Owner sold 2,998,908 shares at the rate of 0.06, making the entire transaction reach 179,934 in total value, affecting insider ownership by 13,005,169. Preceding that transaction, on Dec 12 ’24, Company’s 10% Owner sold 1,614,541 for 0.07, making the whole transaction’s value amount to 113,018. This particular insider is now the holder of 16,004,077 in total.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Let’s observe the current performance indicators for CERo Therapeutics Holdings Inc (CERO). It’s Quick Ratio in the last reported quarter now stands at 0.39. The Stock has managed to achieve an average true range (ATR) of 0.03.
In the same vein, CERO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
Now, what If we examine the latest scores posted by [CERo Therapeutics Holdings Inc, CERO]. During the last 5-days, its volume was better the volume of 21.97 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 9.88% While, its Average True Range was 0.0279.
Raw Stochastic average of CERo Therapeutics Holdings Inc (CERO) in the period of the previous 100 days is set at 1.82%, which indicates a major fall in contrast to 4.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 239.27% that was lower than 250.16% volatility it exhibited in the past 100-days period.
